UBS Maintains Neutral on Viavi Solutions, Lowers Price Target to $44

Benzinga · 1d ago
UBS analyst Andrew Spinola maintains Viavi Solutions (NASDAQ:VIAV) with a Neutral and lowers the price target from $60 to $44.